Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
06/2012
06/21/2012CA2819436A1 Combination therapy of an afucosylated cd20 antibody with a mdm2 inhibitor
06/21/2012CA2818781A1 Human anti-sod1 antibodies
06/21/2012CA2817380A1 Diagnosis and treatments relating to th2 inhibition
06/21/2012CA2814953A1 Methods and compositions for improved f-18 labeling of proteins, peptides and other molecules
06/20/2012EP2465873A1 Eosinophils as a therapeutic target
06/20/2012EP2465872A2 Anti-ADDL Antibodies and uses thereof
06/20/2012EP2465871A1 Methods for generating monovalent IgG
06/20/2012EP2465870A1 Binding polypeptides with diversified and consensus VH/VL hypervariable sequences
06/20/2012EP2465536A1 CD89 activation in therapy
06/20/2012EP2465535A1 Methods for treating conditions associated with MASP-2 dependent complement activation
06/20/2012EP2465534A1 Methods for treating conditions associated with MASP-2 dependent complement activation
06/20/2012EP2465533A1 Methods and compositions comprising supramolecular constructs
06/20/2012EP2465524A1 Autoantibody production inhibitor
06/20/2012EP2465520A2 Epitope sequences
06/20/2012EP2464666A1 Combination of a human interleukin-6 antagonist and a human interleukin-6 receptor antagonist in therapy of tumour diseases
06/20/2012EP2464665A1 Human monoclonal antibody against s. aureus derived alpha-toxin and its use in treating or preventing abscess formation
06/20/2012EP2464664A1 Antibodies against human respiratory syncytial virus (rsv) and methods of use
06/20/2012EP2464657A1 Novel screening strategies for the identification of binders
06/20/2012EP2464383A2 Compositions and methods for the therapy and diagnosis of influenza
06/20/2012EP2464382A1 Combination therapy of an afucosylated cd20 antibody with bendamustine
06/20/2012EP2464380A1 Combination therapy of an afucosylated cd20 antibody with fludarabine and/or mitoxantrone
06/20/2012EP2464220A1 Transgenic animal for production of antibodies having minimal cdrs
06/20/2012EP2364731A9 Methods of administering anti-TNFalpha antibodies
06/20/2012EP2359855A9 Methods of administering anti-TNFalpha antibodies
06/20/2012EP2198026B1 Hepatitis b pre-s2 nucleic acid
06/20/2012EP2129799B1 Methods of stratifying adolescent idiopathic scoliosis, isolated nucleic acid molecules for use in same
06/20/2012EP2075258B1 Antibody against rgd in amino acid sequence of extracellular matrix protein and production method and use of the same
06/20/2012EP1810979B1 STABILIZED HUMAN IgG4 ANTIBODIES
06/20/2012EP1735348B1 Human anti-epidermal growth factor receptor antibody
06/20/2012EP1691837B1 Ip-10 antibodies and their uses
06/20/2012EP1546203B1 Alpha-fetoprotein immu31 antibodies and fusion proteins and methods of use thereof
06/20/2012EP1527080B1 Campylobacter glycans and glycopeptides
06/20/2012EP1463942B2 Methods for purifying protein
06/20/2012EP1452541B1 Hepatitis e virus monoclonal antibodies or the binding fragments of it and the use thereof
06/20/2012CN1906214B Anti-IGFR1 antibody therapeutic combinations
06/20/2012CN102504043A Active dendrobe polysaccharide capable of protecting liver and resisting liver fibrosis and preparation method of antibody affinity chromatography
06/20/2012CN102504027A Preparation of multi-epitope thymidine kinase 1 (TK1) antibody and use of multi-epitope TK1 antibody for early tumor detection and risk early warning in mass physical examination screening
06/20/2012CN102504026A Full human single chain antibody capable of resisting epidermal growth-factor receptor and application thereof
06/20/2012CN102504025A Estrogen receptors and methods of use
06/20/2012CN102504024A Antibodies that bind human interleukin-18 and methods of making and using
06/20/2012CN102504023A Method for preparing egg yolk antibody, egg yolk antibody prepared by method and application of egg yolk antibody
06/20/2012CN102504020A Polypeptide capable of inducing antibody against chicken beta2-microglobulin and use thereof
06/20/2012CN102504016A Amyloid fibrillar oligomer conformational epitope polypeptide and application thereof
06/20/2012CN102499984A Method of treatment and bioassay involving macrophage migration inhibitory factor (mif) as cardiac-derived myocardial depressant factor
06/20/2012CN101988067B Prion isomer monoclonal antibody gene and application thereof
06/20/2012CN101602808B Specific binding protein and application thereof
06/20/2012CN101426526B Solution phase biopanning method using engineered decoy proteins
06/19/2012US8202976 Nucleic acid molecules that encode human anti-IFN-gamma neutralizing antibodies as selective IFN-gamma pathway inhibitors
06/19/2012US8202969 Platelet derived growth factor receptor alpha (PDGFRA) polypeptides comprising activating mutation(s)
06/19/2012US8202518 Antibodies against human cytomegalovirus (HCMV)
06/19/2012US8202517 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof
06/19/2012CA2478012C Internalizing anti-cd74 antibodies and methods of use
06/19/2012CA2474108C Novel fluorescent proteins from aequorea coerulscens and methods for using same
06/19/2012CA2311166C Nucleic acids involved in the responder phenotype and applications thereof
06/19/2012CA2241726C Genes and gene products related to werner's syndrome
06/14/2012WO2012078813A2 Novel modulators and methods of use
06/14/2012WO2012078633A2 Methods of inhibiting metastasis from cancer
06/14/2012WO2012078365A2 Biomarkers for prediction of breast cancer
06/14/2012WO2012078014A1 Recombinant single-chain antibody fragment neutralizing the cytolytic activity of vaginolysin
06/14/2012WO2012077649A1 Human monoclonal antibody
06/14/2012WO2012077643A1 IMMUNOLOGICAL cofilin-1 PROTEIN MEASUREMENT METHOD
06/14/2012WO2012076883A1 Anti ccr4 antibodies and uses thereof
06/14/2012WO2012076868A1 Antibodies to mycobacteria
06/14/2012WO2012076846A1 Polymorphism
06/14/2012WO2012076812A1 Method and case for the in vitro diagnosis of prostate cancer
06/14/2012WO2012076727A1 Antibodies against ror1 and uses thereof
06/14/2012WO2012076663A1 Antitumor combinations containing antibodies recognizing specifically cd38 and bortezomib
06/14/2012WO2012076066A1 Anti-ror1 antibodies and uses thereof
06/14/2012WO2012075581A1 Antibodies selective for cells presenting erbb2 at high density
06/14/2012WO2012023051A9 Anti-lps enriched immunoglobulin preparation for use in treatment and/or prophylaxis of a pathologic disorder
06/14/2012WO2012021841A3 Antibody molecules to oncogenic isoforms of fibroblast growth factor receptor-2 and uses thereof
06/14/2012WO2011027129A9 Treatment of vasculoproliferative conditions
06/14/2012WO2010096418A3 Antibody molecules having specificity for human ox40
06/14/2012US20120151610 Soluble "heavy-chain only" antibodies
06/14/2012US20120149892 Nucleic Acid Molecules Encoding Antibodies That Bind Cell-Associated CA 125/O772P
06/14/2012US20120149884 Specific antibody selection by selective elution conditions
06/14/2012US20120149883 Detection and quantification of modified proteins
06/14/2012US20120149882 Ykl-40 monoclonal antibody
06/14/2012US20120149881 Apoptotic anti-ige antibodies
06/14/2012US20120149879 Bispecific anti-egfr/anti-igf-1r antibodies
06/14/2012US20120149877 Tumor-specific recognition molecules
06/14/2012US20120149876 Stable Heterodimeric Antibody Design with Mutations in the Fc Domain
06/14/2012US20120149875 Affinity chromatography matrix
06/14/2012US20120149765 Sgk1 as diagnostic and therapeutic target
06/14/2012US20120149762 Gene and Protein Relating to Hepatocellular Carcinoma and Methods of Use Thereof
06/14/2012US20120149594 Biomarkers for prediction of breast cancer
06/14/2012US20120149591 In vitro peptide expression library
06/14/2012US20120149095 Dna promoters and anthrax vaccines
06/14/2012US20120149061 Modified Antibody Compositions, Methods of Making and Using Thereof
06/14/2012US20120149044 Inhibition of migration inhibitory factor in the treatment of diseases involving cytokine-mediated toxicity
06/14/2012US20120149031 Anti-cmet antibody and its use for the detection and the diagnosis of cancer
06/14/2012US20120149028 Detection and visualization of the cell cycle in living cells
06/14/2012US20120149026 Insulin resistance marker
06/14/2012US20120148625 Anti-bacterial Vaccine Compositions
06/14/2012US20120148616 Neisseria meningitidis antigens and compositions
06/14/2012US20120148615 Polypeptides from non-typeable haemophilus influenzae
06/14/2012US20120148610 Monomethylvaline compounds capable of conjugation to ligands
06/14/2012US20120148608 Monomethylvaline compounds capable of conjugation to ligands
06/14/2012US20120148607 Anti c-met antibodies
06/14/2012US20120148606 Neutralizing Antibodies And Methods Of Use Thereof
1 ... 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 ... 1494